U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

A pilot, “look-back” study of information about 106 patients with “wet” age-related macular degeneration (AMD) treated at the Wilmer Eye Institute at Johns Hopkins Medicine has revealed that nearly ...

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

The FDA said it cannot approve the application in its present form for the treatment of wet age-related macular degeneration.

The 2024 American Academy of Ophthalmology (AAO) Preferred Practice Patterns provide guidance for physicians about best practices in the treatment of age-related macular degeneration (AMD). The ...

If you don't like getting needles in the arm, imagine getting them in your eyes. That's what people with wet age-related macular degeneration have to do, but thanks to new research, those injections ...

In July 2025, Novartis Pharmaceuticals conducted a study is to assess the effect of Iptacopan to prevent conversion of early ...

Age-related macular degeneration (AMD) is a common reason people lose vision as they get older. It can make it hard to see things in detail. AMD can cause you to lose central vision over time.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are the leading causes of vision impairment in elderly patients and people living with diabetes, respectively.

The most definitive results come from the Age-Related Eye Disease Study (AREDS), published in October of 2001, and its follow-up study (AREDS2), published in May of 2013. AREDS was a very large study ...